IL-2-induced growth of CD8+ T cell prolymphocytic leukemia cells mediated by NF-κB induction and IL-2 receptor α expression

被引:11
|
作者
Arima, N [1 ]
Matsushita, K [1 ]
Suruga, Y [1 ]
Ohtsubo, H [1 ]
Fujiwara, H [1 ]
Hidaka, S [1 ]
Arimura, K [1 ]
Kukita, T [1 ]
Yamaguchi, K [1 ]
Fukumori, J [1 ]
Tanaka, H [1 ]
机构
[1] Kagoshima Univ, Dept Internal Med 1, Kagoshima 890, Japan
关键词
CD8; PLL; NF-kappa B; IL-2; IL-2 receptor alpha; paracrine;
D O I
10.1016/S0145-2126(97)00168-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The binding of interleukin-2 (IL-2) to its receptor on normal T cells induces nuclear expression of nuclear factor kappa B (NF-kappa B), activation of the IL-2 receptor (IL-2R) alpha chain gene, and cell proliferation. In the present study, the role of IL-2R signaling in the growth of CD8(+) T cell prolymphocytic leukemia (T-PLL) cells has been investigated. Flow cytometry revealed that primary leukemia cells from a patient with CD8(+) T-PLL expressed IL-2R alpha and beta chains, and the cells showed a proliferative response and an increase in IL-2R alpha expression on culture with exogeneous IL-2. Northern blot analysis failed to detect IL-2 mRNA, suggesting that IL-2 may act in a paracrine manner in vivo. Electrophoretic mobility-shift assays revealed that recombinant IL-2 increased NF-kappa B binding activity in nuclear extracts of the leukemia cells, and Northern blot analysis showed that IL-2 increased the abundance of mRNAs encoding the NF-kappa B components c-Rel and KBF1 in these cells. IL-2 binding analysis demonstrated that IL-2 markedly increased the number of low affinity IL-2Rs on the leukemia cells, without an effect on the number of high-affinity IL-2Rs. These results show that IL-2 is capable of inducing the nuclear expression of NF-kappa B in primary CD8(+) T-PLL cells, and that this effect is mediated, at least in part, at a pretranslational level. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:265 / 273
页数:9
相关论文
共 50 条
  • [31] IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
    Hinrichs, Christian S.
    Spolski, Rosanne
    Paulos, Chrystal M.
    Gattinoni, Luca
    Kerstann, Keith W.
    Palmer, Douglas C.
    Klebanoff, Christopher A.
    Rosenberg, Steven A.
    Leonard, Warren J.
    Restifo, Nicholas P.
    BLOOD, 2008, 111 (11) : 5326 - 5333
  • [32] Distinct Roles for IL-2 and IL-15 in the Differentiation and Survival of CD8+ Effector and Memory T Cells
    Mitchell, Diana M.
    Ravkov, Eugene V.
    Williams, Matthew A.
    JOURNAL OF IMMUNOLOGY, 2010, 184 (12): : 6719 - 6730
  • [33] Requirement for IL-2 and IL-15 in maintaining memory CD8+ T cells during viral latency
    Hendricks, RL
    Khanna, KM
    Lepisto, AJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U810 - U810
  • [34] Autocrine IL-2 is required for secondary population expansion of CD8+ memory T cells
    Sonia Feau
    Ramon Arens
    Susan Togher
    Stephen P Schoenberger
    Nature Immunology, 2011, 12 : 908 - 913
  • [36] Autocrine IL-2 is required for secondary population expansion of CD8+ memory T cells
    Feau, Sonia
    Arens, Ramon
    Togher, Susan
    Schoenberger, Stephen P.
    NATURE IMMUNOLOGY, 2011, 12 (09) : 908 - U132
  • [37] Modulating DNA Methylation in Activated CD8+ T Cells Inhibits Regulatory T Cell-Induced Binding of Foxp3 to the CD8+ T Cell IL-2 Promoter
    Miller, Michelle M.
    Akaronu, Nnenna
    Thompson, Elizabeth M.
    Hood, Sylvia F.
    Fogle, Jonathan E.
    JOURNAL OF IMMUNOLOGY, 2015, 194 (03): : 990 - 998
  • [38] The two faces of IL-2: a key driver of CD8+ T-cell exhaustion
    Byungsuk Kwon
    Cellular & Molecular Immunology, 2021, 18 : 1641 - 1643
  • [39] IL-4 inhibits human CD8 T cell expression of the common IL-2 receptor gamma chain
    Vyas, B
    Vukmanovic-Stejic, M
    Noble, A
    Kemeny, DM
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1999, 118 (2-4) : 433 - 436
  • [40] CONSTITUTIVE PRODUCTION OF IL-2 BY HUMAN CARCINOMA-CELLS, EXPRESSION OF IL-2 RECEPTOR, AND TUMOR-CELL GROWTH
    LIN, WC
    YASUMURA, S
    SUMINAMI, Y
    SUNG, MW
    NAGASHIMA, S
    STANSON, J
    WHITESIDE, TL
    JOURNAL OF IMMUNOLOGY, 1995, 155 (10): : 4805 - 4816